Luc Morris

Adlerian Chair; Associate Professor; Associate Director

Memorial Sloan Kettering Cancer Center

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Luc Morris serves as the Adlerian Chair and Associate Professor at Memorial Sloan Kettering Cancer Center in the United States. His research focuses on the immune microenvironment in various cancers, including the characterization of immune determinants related to immunotherapy responses and cancer progression. He has contributed to recent publications on topics such as immune escape mechanisms in head and neck cancer and the predictive modeling of immunotherapy outcomes.

Articles (14)

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (2)

Marius Ilié

Professor, PU-PH

Centre Hospitalier Universitaire de Nice

FRANCE

View details

Jonathan Benzaquen

Université Côte d'Azur

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Luc Morris

Research Interests

Explore related searches

Contact this professor

About

Articles (14)

Sympathetic axonogenesis promotes adenoid cystic carcinoma progression

Clinical and Pathologic Characteristics of Cytologically Indeterminate Thyroid Nodules with Non-V600E BRAF Alterations

LORIS robustly predicts patient outcomes with immune checkpoint blockade therapy using common clinical, pathologic and genomic features

Characterizing the Immune Microenvironment and Neoantigen Landscape of Hürthle Cell Carcinoma to Identify Potential Immunologic Vulnerabilities

Loss of Human Leukocyte Antigen and Immune Escape in Head and Neck Cancer

Validation of a Machine Learning Model to Predict Immunotherapy Response in Head and Neck Squamous Cell Carcinoma

Immune Determinants of the Association between Tumor Mutational Burden and Immunotherapy Response across Cancer Types

Mutations in KMT2C, BCOR and KDM5C Predict Response to Immune Checkpoint Blockade Therapy in Non-Small Cell Lung Cancer

Development and Characterization of MYB-NFIB Fusion Expression in Adenoid Cystic Carcinoma

Pre-treatment serum albumin and mutational burden as biomarkers of response to immune checkpoint blockade

Transoral robotic surgery adoption and safety in treatment of oropharyngeal cancers

3p Arm Loss and Survival in Head and Neck Cancer: An Analysis of TCGA Dataset

HPV Status as Prognostic Biomarker in Head and Neck Cancer—Which Method Fits the Best for Outcome Prediction?

Flexible fiber‐based CO2 laser vs monopolar cautery for resection of oral cavity lesions: A single center randomized controlled trial assessing pain and quality of life following surgery

Collaborators (2)

Marius Ilié

Jonathan Benzaquen

Make your next move.